Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer

Get up to date with international insights on assessing and targeting BRCA1/2 and other DNA damage repair gene alterations in pancreatic cancer with downloadable slides and on-demand Webcast from a live Webinar plus an expert commentary.

Share

Program Content

Activities

Pancreatic PARPi Webcast
Global Perspective on BRCA Mutations, PARPi, and Biomarker-Driven Strategies in Pancreatic Cancer
Congratulations: You achieved a completion on 04/09/2022

Activities

PanCa: Molecular Testing
Molecular Testing Considerations for Patients With Pancreatic Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

PanCa: PARPi Therapy
Treatment of Patients With BRCA Mutated Pancreatic Cancer: The Clinical Perspective
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 21, 2020

Expires: September 20, 2021

Activities

Pancreatic PARP Inhibitors
My Perspective on the Use of PARP Inhibition in Pancreatic Cancer Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 30, 2020

Expires: October 29, 2021

Faculty

cover img faculity

Dirk Arnold, MD, PhD

Director
Asklepios Tumorzentrum Hamburg
Department of Oncology
AK Altona
Hamburg, Germany

cover img faculity

Michael J. Pishvaian, MD, PhD

Associate Professor
Sidney Kimmel Cancer Center
Johns Hopkins University
Director
Clinical Research, GI and Phase I Oncology in the National Capital Region
Johns Hopkins at Sibley Memorial Cancer Center
Washington, DC

Supporters

Supported by an educational grant from

AstraZeneca